login

 

The EIT Health Startups Meet Pharma is a challenge-based acceleration program connecting startups developing innovative solutions for chronic care with key pharma partners in Europe. The program had its premiere in 2019 with 14 healthcare startups from all over Europe that tackled five different challenges set up by EIT Health Partners Amgen, Bayer, Ferrer, Janssen and UCB. Read more about the 2019 edition.

In 2020, five challenges have been released in collaboration with four EIT Health Partners: Amgen, Bayer, Beiersdorf and Boehringer Ingelheim.

Programme structure

Module 1 (June 29-July 3, Heidelberg) : 5 days “Innovation & Entrepreneurship training”.  Startups receive tailored workshops by pharma experts on the different tools and methods to successfully build their business.

Module 2 (July 15-25 in Heidelberg) : 5 days workshops by pharma partners on how to collaborate with big players in the market.

Module 3 (September 2020): Startups visit selected pharma companies to discuss collaboration opportunities.

Module 4 (November 2020 – date & location TBD) : Demo Day. Startups pitch their achievements in front of Investors and EIT Health stakeholders.

Gold sponsors:

Silver sponsor:

Challenge #1

Pharma company: Amgen

Title: Encourage continuity in treatment strategy and treatment optimization for post-myocardial infarction patients

Disease Area: Cardiology

Looking for: a) a predictive analytic tool to identify very high risk patients & b) a procedure/tool which will provide a holistic support to post-MI patients after discharge.

Selected startups

Predictive cardiac analytics cloud platform of completest cardiac signal processing and analysis to automate electrocardiogram interpretation for doctors and serve greater longevity of patients.

Cardiolyse

Collaborate Health Cloud
is a modern patient management & collaboration tool, which helps doctors reduce errors and increase patient compliance to medical plans by facilitating diagnostic
and communication tasks.

Collaborate Healthcare P.C

Cievert uses technology to optimise post-discharge pathways by automatically monitoring patients, stratifying risk and providing personalised information.

Cievert

HumanITcare is a platform that delivers disruptive ways of monitoring real-life data on the behavior of chronic patients by using digital biomarkers.

HumanITcare

Parsek´s Vitaly Care Management Solution is a patient-centric tool that enables care coordination by a Multidisciplinary Care Team, it uses various disease-specific care pathway templates (Care Maps), which can be applied to any chronic disease.

Parsek Information Technologies

Challenge #2

Pharma company: Amgen

Title: Choosing the right treatment for Multiple Myeloma patients

Disease area: Multiple Myeloma

Looking for:Creation of an algorithm, that would help physicians choosing the right treatment for Multiple Myeloma patients

Selected startups

Proteona provides in depth molecular insights to researchers and clinicians using its proprietary single cell proteogenomics platform and AI-assisted bioinformatics.

Proteona

BioXplor Oncology AI is an intelligent state-of-the-art NLP-knowledge discovery and AI-drug discovery platform for oncology.

BioXplor

In vitro screening of potential chemotherapeutics in patient cells grown in 3D on LifeGel to choose the right treatment in one week.

Real Research Sp. z o.o.

Filling the gap between data and precision medicine through decision support based on Big Data Analytics, Artificial Intelligence and Microservices Software Architectures.

KAZAAM Lab S.R.L.

Challenge #3

Pharma company: Bayer AG

Title: Disruptive Gene therapies, cell therapies and delivery technologies for different therapeutic areas

Disease Area: Cardiology, Oncology, Gynecology, Ophthalmology, Hematology and Women’s Health

Looking for: Disruptive technologies useful in the therapeutic areas of Cardiology, Oncology, Gynecology, Ophthalmology, Hematology and Women’s Health – or ideally for all of those as a platform technology. Breakthrough innovations for other or multiple indications might be of interest as well.

Sneak peak into the selected startups

Selected startups

Development of C3P3 artificial expression system for synthetic gene therapy and bioproduction.

Eukarÿs

Challenge #4

Pharma company: Boehringer Ingelheim

Title: Portable Interstitial Lung Disease (ILD) Diagnostic Tool

Disease Area: Interstitial Lung Diseases

Looking for: Portable Interstitial Lung Disease (ILD) Diagnostic Tool

Selected startups

eMurmer utilizes a low-cost electronic sensor in combination with lung sound AI to enable non-experts to perform ILD screening by integrating it into the existing CE-marked and FDA-cleared eMurmur platform.

eMurmer

ArtiQ developed AI-based software to help doctors save their time and improve accuracy when diagnosing lung diseases.

ArtiQ

IPDx is developing a saliva-based to help doctors save their time point of care test to diagnose ILDs

IPDx

Carbomed Medical Solutions is extending its CO2 measurement technology to provide support in detection and monitoring of Portable Interstitial Lung Disease (ILD).

Carbomed Medical Solutions

Challenge #5

Pharma company: Beiersdorf AG

Title: Improving the condition of diabetic skin

Disease Area: Diabetes, Skin

Looking for: BioTech, MedTech or Digital Health solutions to improve the condition of diabetic skin

Sneak peak into the selected startups.

Selected startups

Synoia Technologies specializes in developing a product integrating multiple technologies together with treatment capsules
for diabetic skin condition.

Synoia Technologies

Development of a unique technology based on ceramic nanoporous MicroNeedle Arrays (npMNA), which allows to locally deliver antibacterial and antifungal drugs.

My Life Technologies